These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 16988199)

  • 1. Clinical trial design issues: at least 10 things you should look for in clinical trials.
    Glasser SP; Howard G
    J Clin Pharmacol; 2006 Oct; 46(10):1106-15. PubMed ID: 16988199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The quality of reporting and outcome measures in randomized clinical trials related to upper-extremity disorders.
    Gummesson C; Atroshi I; Ekdahl C
    J Hand Surg Am; 2004 Jul; 29(4):727-34; discussion 735-7. PubMed ID: 15249101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A critical assessment of the quality of reporting of randomized, controlled trials in the urology literature.
    Scales CD; Norris RD; Keitz SA; Peterson BL; Preminger GM; Vieweg J; Dahm P
    J Urol; 2007 Mar; 177(3):1090-4; discussion 1094-5. PubMed ID: 17296417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and analysis of group-randomized trials in cancer: a review of current practices.
    Murray DM; Pals SL; Blitstein JL; Alfano CM; Lehman J
    J Natl Cancer Inst; 2008 Apr; 100(7):483-91. PubMed ID: 18364501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of reporting controlled clinical trials on treatment of the acute mania phase of bipolar disorder with new antipsychotic drugs.
    Arbaizar B; Gómez-Acebo I; Llorca J
    Pharmacopsychiatry; 2008 Nov; 41(6):240-1. PubMed ID: 19067261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement in the quality of randomized controlled trials among general anesthesiology journals 2000 to 2006: a 6-year follow-up.
    Greenfield ML; Mhyre JM; Mashour GA; Blum JM; Yen EC; Rosenberg AL
    Anesth Analg; 2009 Jun; 108(6):1916-21. PubMed ID: 19448222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blinded trials taken to the test: an analysis of randomized clinical trials that report tests for the success of blinding.
    Hróbjartsson A; Forfang E; Haahr MT; Als-Nielsen B; Brorson S
    Int J Epidemiol; 2007 Jun; 36(3):654-63. PubMed ID: 17440024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and factors associated with use of placebo control groups in randomized controlled trials in psoriasis: a cross-sectional study.
    Katz KA; Karlawish JH; Chiang DS; Bognet RA; Propert KJ; Margolis DJ
    J Am Acad Dermatol; 2006 Nov; 55(5):814-22. PubMed ID: 17052487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Who is blinded in randomized clinical trials? A study of 200 trials and a survey of authors.
    Haahr MT; Hróbjartsson A
    Clin Trials; 2006; 3(4):360-5. PubMed ID: 17060210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Better conduct of clinical trials: the control group in critical care trials.
    Takala J
    Crit Care Med; 2009 Jan; 37(1 Suppl):S80-90. PubMed ID: 19104230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placebo controls: scientific and ethical issues.
    Kowalski CJ
    Am J Bioeth; 2002; 2(2):33-4. PubMed ID: 12189073
    [No Abstract]   [Full Text] [Related]  

  • 12. Reporting adverse events in randomized controlled trials.
    Nuovo J; Sather C
    Pharmacoepidemiol Drug Saf; 2007 Mar; 16(3):349-51. PubMed ID: 16998947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating ethics consultation: randomised controlled trial is not the right tool.
    Chen YY; Chen YC
    J Med Ethics; 2008 Aug; 34(8):594-7. PubMed ID: 18667647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trials in the new millennium.
    DeMets DL
    Stat Med; 2002 Oct; 21(19):2779-87. PubMed ID: 12325093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Planning a cluster randomized controlled trial: methodological issues.
    Christie J; O'Halloran P; Stevenson M
    Nurs Res; 2009; 58(2):128-34. PubMed ID: 19289934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival end point reporting in randomized cancer clinical trials: a review of major journals.
    Mathoulin-Pelissier S; Gourgou-Bourgade S; Bonnetain F; Kramar A
    J Clin Oncol; 2008 Aug; 26(22):3721-6. PubMed ID: 18669458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reporting of informed consent, standard of care and post-trial obligations in global randomized intervention trials: a systematic survey of registered trials.
    Cohen ER; O'Neill JM; Joffres M; Upshur RE; Mills E
    Dev World Bioeth; 2009 Aug; 9(2):74-80. PubMed ID: 18445072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The design and interpretation of pilot trials in clinical research in critical care.
    Arnold DM; Burns KE; Adhikari NK; Kho ME; Meade MO; Cook DJ;
    Crit Care Med; 2009 Jan; 37(1 Suppl):S69-74. PubMed ID: 19104228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The intention-to-treat approach in randomized controlled trials: are authors saying what they do and doing what they say?
    Gravel J; Opatrny L; Shapiro S
    Clin Trials; 2007; 4(4):350-6. PubMed ID: 17848496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eliminating bias in randomized controlled trials: importance of allocation concealment and masking.
    Viera AJ; Bangdiwala SI
    Fam Med; 2007 Feb; 39(2):132-7. PubMed ID: 17273956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.